Form D · Biotechnology

Replicate Bioscience, Inc.

San Diego, CA · CIK 0001846344

Offering snapshot reported Mar 9, 2022 · SEC filing

Reported sold
$20M
Offering amount: $53M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 4, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$10M$20MFeb 16, 2021: $6,000,000.00Feb 16, 2021Mar 9, 2022: $20,000,000.00Mar 9, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,000,000 → $20,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 9, 2022Amendment$20,000,000$14,000,000vs Feb 16, 20211SEC filing
Feb 16, 2021Initial$6,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-389517

Source: Form D, filed Mar 9, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Ehlers Director, Executive
Seth Harrison Director
Nathaniel Wang Director, Executive
Joseph Yanchik Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10210 Campus Point Drive #150
San Diego, CA, 92121